纳米材料在癌症免疫治疗中的成就应用和未来
Kairui Zhu1, Weimiao Sun2, Chenhui Ti2
1The Second Medical College of Binzhou Medical University, Yantai, Shandong 264003, China; Department of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, Shandong, China.
International immunopharmacology
|June 6, 2025
概括
纳米材料为克服癌症免疫疗法的挑战提供了有希望的解决方案,提高了药物输送和治疗效率. 本综述探讨了用于各种癌症治疗的有机和无机纳米材料,并讨论了未来的方向.
科学领域:
- 在瘤学瘤学.
- 材料科学 材料科学 材料科学
- 免疫学 免疫学 免疫学
背景情况:
- 癌症免疫疗法面临的局限性包括药物输送不良,瘤透率低,以及不良反应.
- 纳米材料在纳米尺度上具有独特的特性,使其能够增强治疗应用.
- 这些材料提供了诸如精确准,可控释放和改善透率等优势,用于癌症治疗.
研究的目的:
- 审查有机和无机纳米材料在癌症免疫治疗中的应用.
- 探索纳米材料的使用与化疗,光疗,辐射疗法和基因疗法结合使用.
- 讨论纳米材料在免疫治疗中的当前挑战和未来前景.
主要方法:
- 对癌症治疗中纳米材料现有研究的文献综述.
- 将纳米材料分为有机和无机类型的分类.
- 分析纳米材料在各种癌症治疗模式中的应用.
主要成果:
- 纳米材料在克服癌症免疫治疗中的关键挑战方面具有显著的潜力.
- 纳米材料在免疫疗法,化疗,光疗和基因疗法中发现了多种应用.
- 有机和无机纳米材料在向药物输送和改善治疗结果方面都很有前途.
结论:
- 纳米材料对于通过改善药物输送和疗效来推进癌症免疫疗法至关重要.
- 对基于纳米材料的治疗方法的进一步研究对个性化癌症治疗具有重大前景.
- 应对当前的挑战将为纳米材料在瘤学中的更广泛的临床应用铺平道路.
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Vaccines
522
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
522
Cytotoxic T Cells-mediated Immune Response
2.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K


